126 related articles for article (PubMed ID: 37714042)
1. Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury.
Muhammad W; Zhang Y; Zhu J; Xie J; Wang S; Wang R; Feng B; Zhou J; Chen W; Xu Y; Yao Q; Yu Y; Cao H; Gao C
Biomater Adv; 2023 Nov; 154():213621. PubMed ID: 37714042
[TBL] [Abstract][Full Text] [Related]
2. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment.
Muhammad W; Zhu J; Zhai Z; Xie J; Zhou J; Feng X; Feng B; Pan Q; Li S; Venkatesan R; Li P; Cao H; Gao C
Acta Biomater; 2022 Aug; 148():258-270. PubMed ID: 35724918
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anti-oxidant and anti-inflammatory effects of ceria/resatorvid co-decorated nanoparticles for acute lung injury therapy.
Wu Y; Zhang Y; Tang X; Ye S; Shao J; Tu L; Pan J; Chen L; Liang G; Yin L
J Nanobiotechnology; 2023 Dec; 21(1):502. PubMed ID: 38129906
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment.
Li P; Pan J; Dong Y; Sun Y; Wang Y; Liao K; Chen Y; Deng X; Yu S; Hu H
J Control Release; 2024 Jan; 365():219-235. PubMed ID: 37992874
[TBL] [Abstract][Full Text] [Related]
5. [Biofilm Eradication Four-Step Strategy: Study of Using Self-Assembled Azithromycin/Rhamnolipid Nanoparticles for Removing
Dong YT; Li PY; Sun YY; Rao YQ; Yu SH; Hu HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):598-604. PubMed ID: 34323037
[TBL] [Abstract][Full Text] [Related]
6. Polyphosphazene nanodrugs for targeting delivery and inflammation responsive release of curcumin to treat acute lung injury by effectively inhibiting cytokine storms.
Su X; Jing X; Jiang W; Li M; Liu K; Teng M; Ma Y; Wang D; Meng L; Zhang Y; Ji W
Colloids Surf B Biointerfaces; 2023 Sep; 229():113446. PubMed ID: 37481805
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-loaded ROS-responsive poly(thioketal) nanoparticles suppress inflammation and oxidative stress of acute lung injury.
Zhai Z; Ouyang W; Yao Y; Zhang Y; Zhang H; Xu F; Gao C
Bioact Mater; 2022 Aug; 14():430-442. PubMed ID: 35415281
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury.
Zhang CY; Lin W; Gao J; Shi X; Davaritouchaee M; Nielsen AE; Mancini RJ; Wang Z
ACS Appl Mater Interfaces; 2019 May; 11(18):16380-16390. PubMed ID: 30973702
[TBL] [Abstract][Full Text] [Related]
9. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 targeted and ROS-responsive nanoparticles for the treatment of acute lung injury.
Ran Y; Yin S; Xie P; Liu Y; Wang Y; Yin Z
Nanoscale; 2024 Jan; 16(4):1983-1998. PubMed ID: 38189459
[TBL] [Abstract][Full Text] [Related]
11. The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice.
Jiang J; Jian Q; Jing M; Zhang Z; Zhang G; Shan L; Yu P; Wang Y; Xu L
Int Immunopharmacol; 2019 Jan; 66():109-118. PubMed ID: 30447529
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro.
Speer EM; Dowling DJ; Xu J; Ozog LS; Mathew JA; Chander A; Yin D; Levy O
PLoS One; 2018; 13(5):e0196352. PubMed ID: 29715306
[TBL] [Abstract][Full Text] [Related]
13. Fe-Curcumin Nanozyme-Mediated Reactive Oxygen Species Scavenging and Anti-Inflammation for Acute Lung Injury.
Yuan R; Li Y; Han S; Chen X; Chen J; He J; Gao H; Yang Y; Yang S; Yang Y
ACS Cent Sci; 2022 Jan; 8(1):10-21. PubMed ID: 35106369
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of tea polyphenol-loaded nanoparticles coated with platelet membranes on LPS-induced lung injury.
Jin H; Zhao Y; Yao Y; Zhao J; Luo R; Fan S; Wei Y; Ouyang S; Peng W; Zhang Y; Pi J; Huang G
Biomater Sci; 2023 Sep; 11(18):6223-6235. PubMed ID: 37529873
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NLRP9b attenuates acute lung injury through suppressing inflammation, apoptosis and oxidative stress in murine and cell models.
Yanling Q; Xiaoning C; Fei B; Liyun F; Huizhong H; Daqing S
Biochem Biophys Res Commun; 2018 Sep; 503(2):436-443. PubMed ID: 29655793
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhetinic acid alleviates acute lung injury by PI3K/AKT suppressing macrophagic Nlrp3 inflammasome activation.
Wang K; Zhang Y; Cao Y; Shi Z; Lin Y; Chen Y; Zhao H; Liu X
Biochem Biophys Res Commun; 2020 Nov; 532(4):555-562. PubMed ID: 32900490
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
18. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
[TBL] [Abstract][Full Text] [Related]
19. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
[TBL] [Abstract][Full Text] [Related]
20. Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species.
Nadeem A; Al-Harbi NO; Ahmad SF; Ibrahim KE; Siddiqui N; Al-Harbi MM
Clin Exp Immunol; 2018 Mar; 191(3):279-287. PubMed ID: 29277898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
